Tirzepatide Cost in Minnesota (2026)

Tirzepatide pricing across Minnesota

Covered like everywhere the pharmacies are licensed:

Telehealth has flattened the map for GLP-1 pricing in Minnesota: the same verified compounded tirzepatide programs that serve the rest of the country ship here, at the same all-in rates — $215 to $597 a month at the 10 mg maintenance basis — so a patient in Minneapolis pays what a patient in St. Paul pays.

Whether you're in Minneapolis, St. Paul, or Bloomington, the pipeline is identical — online clinical evaluation, state-licensed pharmacy fulfillment, refrigerated shipping, remote titration support — which is why the telehealth band undercuts the $399–$650/month quotes typical of in-person programs in the state.

The verified floor for Minnesota is NexLife at $215 a month — flat at every dose from 2.5 to 15 mg, no membership fee, free expedited shipping, consultation included, with published 50-state availability and a named six-pharmacy network (503A pharmacies and FDA-registered 503B facilities). Multi-month plans step down to $195, $190, and $186 (3/6/12-month), and NexLife's semaglutide runs $145–$165.

Behind the floor sit Yucca at $258 (six-month-plan terms), IVIM and Mochi at $278 all-in once mandatory memberships are counted, and ShedRx reaching $289 at the 10 mg tier — the full field, with every condition attached, is on the ranking page.

Coverage inside the state runs the full roster — Minneapolis, St. Paul, Rochester, Duluth, Bloomington — because shipping licenses are statewide; the city chips above are search targets, not service boundaries.

Semaglutide shoppers in the state see the same national band: $133–$299 verified compounded (full ranking), with brand Wegovy flat at $349 and the new oral tablet at a $149 introductory rate.

Retail brand pickup is unusually practical across the region since the March 2026 KwikPen rollout put $449 Zepbound at big-box pharmacy counters. Twelve-month math favors the flat programs: the verified floor annualizes to $2,580 with zero lock-in, versus prepaid alternatives from about $2,028 with money committed up front — the trade priced on the annual-cost page.

Every figure above carries a capture date in the downloadable dataset; confirm at checkout — this market reprices monthly, in Minnesota exactly as everywhere.

City by city

Minneapolis. Minnesota’s search demand for GLP-1s concentrates here, and the answer is the statewide one: intake online, $399–$650/month-range local clinics undercut by the $215 telehealth floor, cold-chain delivery in 3–7 days to any Minneapolis address.

St. Paul. Nothing local moves the number — a St. Paul ZIP gets the same $215 verified floor, the same named-pharmacy options, and the same 3–7-day shipping as the rest of Minnesota; what St. Paul does add is retail convenience for the brand fallback, with $449 Zepbound KwikPens at chain counters since March 2026.

Rochester. Med-spa and clinic quotes around Rochester commonly land at $399–$650/month for compounded product; the telehealth board serves the same molecule from $215 all-in, and the delta is pure delivery model, not medicine.

Duluth. For Duluth shoppers the practical checklist is short: confirm the program ships to your ZIP (they do, statewide), confirm the maintenance-dose price in writing, and benchmark any local quote against the $215 floor before signing anything.

Bloomington. Bloomington illustrates the state pattern in miniature — identical telehealth pricing to every smaller Minnesota town, plus dense pharmacy access that makes the brand retail route a same-day fallback when a compounded program stumbles.

Semaglutide in Minnesota

If the budget molecule is the target, Minnesota buyers see the national verified band of $133–$299 all-in — led by Oak Longevity at $133 (flat, no subscription), NexLife at $145 on a 12-month plan ($165 month-to-month; $149/$147 mid-terms; microdose from $129), and Yucca at $146 — all shipping statewide. On the brand side nothing varies by state: Wegovy $349 flat, $199 × 2 starter fills, $149 oral intro — details and every program’s conditions in the semaglutide ranking.

Brand-name access in Minnesota

The FDA-approved route is state-uniform and increasingly practical: Zepbound at $299–$449 via LillyDirect — and, since March 2026, KwikPens at retail counters including Walmart across Minnesota at the same tiers — roughly $350 on TrumpRx, and about a $50 monthly copay for newly eligible Medicare patients under the mid-2026 Part D expansion. Keep the ~45-day refill cadence or LillyDirect’s pricing lapses to $599–$1,049; the brand guide covers every channel.

Using insurance in Minnesota

Before any cash number on this page, run the coverage check: with a commercial plan plus manufacturer savings card, covered copays run as low as $25/month; roughly 43% of large employers now include weight-loss medication (re-check every open enrollment); and the indication side doors — Wegovy’s cardiovascular indication, Zepbound’s sleep-apnea indication, any diabetes diagnosis — route around “weight loss excluded” language for Minnesota patients with the qualifying condition. The playbook, including the appeal that works: the coverage guide.

What a Minnesota year costs

Annualized at standing rates, the verified compounded tirzepatide board runs $2,580–$7,164 for year one — the floor being NexLife’s $2,580 with zero lock-in — against prepaid effectives from about $2,028 (Found) and $2,232 (NexLife’s 12-month tier), Wegovy’s $4,188 flat year, and Zepbound’s ~$5,188 standard-titration first year. Full annual math per program: the 12-month cost page.